Literature DB >> 427725

Blocking factors in sera of breast cancer patients.

F Tanaka, R H Yonemoto, S R Waldman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 427725     DOI： 10.1002/1097-0142(197903)43:3<838::aid-cncr2820430309>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  4 in total

1.  Supernatant derived from a human hepatocellular carcinoma cell line (PLC/PRF/5) activates a population of T-suppressor cells.

Authors:  A Keong; A R Rabson
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

2.  Comparison of serum blocking factors on leucocyte adherence inhibition and PHA lymphocyte blastogenesis in breast cancer patients.

Authors:  T Fujisawa; R H Yonemoto; S R Waldman
Journal:  Jpn J Surg       Date:  1981

3.  Immune reactive proteins as prognostic and clinical markers in malignant cervical neoplasia.

Authors:  M Radhakrishna Pillai; P Balaram; N K Hareendran; S Bindu; T Abraham; T K Padmanabhan; M K Nair
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

4.  Experimental paracoccidioidomycosis in the Syrian hamster. Morphology and correlation of lesions with humoral and cell-mediated immunity.

Authors:  M T Peraçoli; N G Mota; M R Montenegro
Journal:  Mycopathologia       Date:  1982-07-23       Impact factor: 2.574
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.